Article Archive for:
The attorneys of the Mellino Robenalt, LLC work hard to share legal expertise with the community. Bringing you the most up-to-date information on surgical errors, medical injuries to children, and other medical malpractice issues is of upmost importance. We specialize in these types of cases, and regularly share our legal research to keep you informed.
Posted on: Thursday, March 26th, 2009
Birth trauma litigation is a very complex area of the law, and only a highly skilled attorney with an extensive track record in this area is able to ensure justice for the family. Birth trauma usually refers to situations where children are victims of medical malpractice as they are being born. They may suffer significant injuries or death during, or as the result of something going wrong with the pregnancy or during delivery. “This is to be clearly distinguished from birth defects that happen prior to birth and were likely the result of genetic flaws or other processes during the [...]
Read the rest of this entry »
Posted on: Thursday, March 26th, 2009
In most instances amputation is thought of as the removal of a body part via surgery or trauma. It is usually performed to stop the spread of a disease or limit an existing malady. Amputation has a rather colorful history starting in the 15th century when doctors performed surgical intervention on gangrenous or severely injured limbs. “Needless to say the results were often less than perfect due to infection and major blood loss,” indicated Christopher Mellino, of the Mellino Law Firm in Cleveland, Ohio. Amputations weren’t performed with any degree of frequency until the 19th century when anesthesia was introduced [...]
Read the rest of this entry »
Posted on: Thursday, March 26th, 2009
Propulsid was supposedly designed to solve acid reflux; instead its side effects caused fatal heart rhythm abnormalities. Propulsid/Cisapride was made by Janssen Pharmaceutical and was supposed to handle nighttime heartburn by moving food out of the stomach, and keeping acid away from the esophagus. It was approved by the Food and Drug Administration (FDA) in 1993, and was marketed as being able to tighten the valve between the esophagus and the stomach. For three years there was no warning label about the drugs effect on people’s heart rhythms. Then adverse event reports began coming in, prompting Janssen Drugs to warn [...]
Read the rest of this entry »